Cargando…

The impact of immunohistochemical markers of Ki-67 and p53 on the long-term outcome of growth hormone-secreting pituitary adenomas: A cohort study

BACKGROUND AND OBJECTIVES: The tumoral biomarkers have a rather well known effect upon the tumor control period of several types of malignant lesions. The aim of this study was to evaluate the impact of immunohistochemical (IHC) markers of Ki-67 and p53 on the long-term outcome of growth hormone (GH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alimohamadi, Maysam, Ownagh, Vahid, Mahouzi, Leila, Ostovar, Afshin, Abbassioun, Kazem, Amirjmshidi, Abbas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323896/ https://www.ncbi.nlm.nih.gov/pubmed/25685203 http://dx.doi.org/10.4103/1793-5482.142732

Ejemplares similares

Association of Ki-67 Labelling Index and IL-17A with Pituitary Adenoma
por: Glebauskiene, Brigita, et al.
Publicado: (2018)

Immunohistochemical Evaluation of p53 and Ki67 Expression in Skin Epithelial Tumors
por: Khodaeiani, Effat, et al.
Publicado: (2013)

Immunohistochemical expression of P53, Ki-67, and CD34 in psoriasis and psoriasiform dermatitis
por: Ramezani, Mazaher, et al.
Publicado: (2019)

Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas
por: Mastronardi, Luciano, et al.
Publicado: (2001)

Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas
por: Yao, Xiaohui, et al.
Publicado: (2017)

Prediction of Higher Ki-67 Index in Pituitary Adenomas by Pre- and Intra-Operative Clinical Characteristics
por: Wang, Xuanzhi, et al.
Publicado: (2022)

PMON126 Null Cell Adenoma With Low Ki-67 Presenting as Recurrent Pituitary Mass
por: Tiu, Leo, et al.
Publicado: (2022)

Immunohistochemical detection of Hsp90 and Ki-67 in pterygium
por: Sebastiá, Roberto, et al.
Publicado: (2013)

Immunohistochemical expression of β-catenin, Ki67, CD3 and CD18 in canine colorectal adenomas and adenocarcinomas
por: Herstad, Kristin M. V., et al.
Publicado: (2021)

Breastfeeding and Immunohistochemical Expression of ki-67, p53 and BCL2 in Infiltrating Lobular Breast Carcinoma
por: Gonzalez-Sistal, Angel, et al.
Publicado: (2016)

IMMUNOHISTOCHEMICAL ANALYSIS BY KI67 AND IDH1 IN PATIENTS WITH CHONDROSARCOMA
por: RIBEIRO, MARCELO BARBOSA, et al.
Publicado: (2023)

Immunohistochemical Profile of Nonfunctioning Pituitary Adenomas
por: Solovey, Mariana, et al.
Publicado: (2021)

Prognostic Value of Immunohistochemical Staining of p53, bcl-2, and Ki-67 in Small Cell Lung Cancer
por: Paik, Kwang Hyun, et al.
Publicado: (2006)

Immunohistochemical Expression of Ki67 and p53 in Wilms Tumor and Its Relationship with Tumor Histology and Stage at Presentation
por: Krishna, O. H. Radhika, et al.
Publicado: (2016)

Immunohistochemical expression of Ki-67, p53, and CD10 in phyllodes tumor and their correlation with its histological grade
por: Shubham, Swasti, et al.
Publicado: (2019)

Clinical Significance of Ki-67 Labeling Index in Pituitary Macroadenoma
por: Paek, Kyung-Il, et al.
Publicado: (2005)

Immunohistochemical expression of osteonectin, matrix metalloproteinases-9 and Ki-67 in ameloblastoma
por: Indirapriyadarsini, K, et al.
Publicado: (2018)

Immunohistochemical Evaluation of Ki-67 and Comparison with Clinicopathologic Factors in Breast Carcinomas
por: Aman, Nguiessan Alphonse, et al.
Publicado: (2019)

Maspin, Syndecan-1, and Ki-67 in the Odontogenic Keratocyst: An Immunohistochemical Analysis
por: Hammad, Huda M., et al.
Publicado: (2020)

Associations of Ki-67 Labeling Index with Clinical and Paraclinical Features of Growth Hormone-Secreting Pituitary Adenomas: A Single Center Report from Iran
por: Mohseni, Shahrzad, et al.
Publicado: (2019)

Does immunohistochemical staining of P53, Ki 67 and cyclin A accurately predict Wilms tumor recurrence and survival?
por: Atwa, Ahmed M, et al.
Publicado: (2022)

Immunohistochemical (Ki-67) study of endometrial maturation in mice after use of phosphodiesterase type 5 inhibitor
por: Rashidi, Bahman, et al.
Publicado: (2015)

Cytohistological correlation in pituitary tumor and immunological assessment with the help of Ki-67
por: Sen, A, et al.
Publicado: (2017)

Evaluation of prognostic utility of Ki-67, P53, and O-6-methylguanine-DNA methyltransferase expression in pituitary tumors
por: Das, Chhanda, et al.
Publicado: (2019)

Immunohistochemical analysis of Ki-67 in dental follicle of asymptomatic impacted third molars
por: Kucukkolbasi, Hasan, et al.
Publicado: (2014)

Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: An immunohistochemical study
por: Humayun, S., et al.
Publicado: (2011)

P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas
por: Sundov, Dinka, et al.
Publicado: (2013)

Significance of p53 and ki-67 expression in prostate cancer
por: Verma, Renuka, et al.
Publicado: (2015)

MON-417 Is There a Cut-Off of Ki-67 Indicative of Pituitary Carcinoma?
por: Ferreira, Maria João, et al.
Publicado: (2019)

Immunohistochemical detection of laminin-1 and Ki-67 in radicular cysts and keratocystic odontogenic tumors
por: Ayoub, Mohamed S, et al.
Publicado: (2011)

Automated Ki-67 Quantification of Immunohistochemical Staining Image of Human Nasopharyngeal Carcinoma Xenografts
por: Shi, Peng, et al.
Publicado: (2016)

An Immunohistochemical Study Showing Ki-67 as an Analytical Marker in Oral Malignant and Premalignant Lesions
por: Dash, Kailash C, et al.
Publicado: (2020)

An Immunohistochemical Study on Ki-67 Expression in Squamous Cell Carcinomas of Cervix With Clinicopathological Correlation
por: R, Devaki Priyanka, et al.
Publicado: (2023)

Expression of Cyclooxygenase-2, p53 and Ki-67 in Gastric Cancer
por: Joo, Young-Eun, et al.
Publicado: (2006)

Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
por: Park, H. R., et al.
Publicado: (1995)

Radiomic prediction models for the level of Ki-67 and p53 in glioma
por: Sun, Xiaojun, et al.
Publicado: (2020)

Immunoexpression of Ki67, p53 and cyclin D1 in osteosarcomas
por: Niculescu, Ştefan Adrian, et al.
Publicado: (2021)

Evaluation of P57, P53 and Ki67 Expression in Meningiomas
por: Küçükosmanoğlu, İlknur, et al.
Publicado: (2022)

The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study
por: Ahadi, Mahsa, et al.
Publicado: (2020)

Initial Experience with Diffusion-weighted Imaging to Predict the Tumor Consistency and Surgical Success in Solid Growth Hormone Producing Pituitary Macroadenomas
por: Alimohamadi, Maysam, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k1s0nfjk2rjqnib7kq6dq7j57j